MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Age-associated Changes in Microglial Morphology and its Role in Deciphering Susceptibility to Parkinson’s Disease

    S. Choudhury, P. Abhilash, P. Alladi (Bengaluru, India)

    Objective: To delineate the age-associated changes in microglial morphotypes in the substantia nigra pars compacta (SNpc) of C57BL/6J and CD-1 mice and alterations in response…
  • 2024 International Congress

    Longitudinal Studies of LFP Activities During Acute and Chronic DBS Stimulation in PD Patients

    Y. Zhao, V. Rayudu, S. Santacruz, M. Varga (Austin, USA)

    Objective: This study investigates the changes in local field potential (LFP) during acute and chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD)…
  • 2024 International Congress

    Alpha-synuclein aggregate pathology in the cranial sensorimotor system in a mouse model of Parkinson’s disease.

    A. Schaser (West Lafayette, USA)

    Objective: The goal of this study was to examine the effect of a potential underlying mechanism responsible for the complex voice deficits that exist in…
  • 2024 International Congress

    Phenotypic characterization of an ATP13A2 knockout rat model of Parkinson’s disease

    R. Kinet, J. Sikora, ML. Arotcarena, M. Decourt, E. Balado, E. Doudnikoff, E. Bezard, PO. Fernagut, B. Dehay (BORDEAUX, France)

    Objective: This project aimed to characterize the first-ever transgenic ATP13A2 knockout rat model to elucidate the underlying mechanisms of ATP13A2-associated pathology. Background: Most Parkinson’s disease…
  • 2024 International Congress

    Cervical Vestibular-Evoked Myogenic Potentials in Patients with Parkinson’s Disease

    E. Abed (Cairo, Egypt)

    Objective: to examine the functioning of the brain stem and to gain insight into the irregularities of cervical vestibular-evoked myogenic potentials (cVEMPs) in patients with…
  • 2024 International Congress

    Predictive Accuracy of Baseline DaT-SPECT for Freezing of Gait at 5, 7, and 10-year Follow up in The PPMI Cohort

    J. Li, R. Rajmohan, J. Ruiz Tejeda, N. Phielipp (Irvine, USA)

    Objective: To see if segmentation models of baseline DaT-SPECT striatal binding ratios (SBR) will predict freezing of gait (FoG) in Parkinson’s Disease over a 5,…
  • 2024 International Congress

    Prokineticin-2 is highly expressed in colonic mucosa of early Parkinson’s disease patients

    G. Bellini, G. Palermo, F. Rettura, E. Del Prete, E. Unti, C. Ippolito, C. Pellegrini, D. Frosini, N. Bernardini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the expression of PK2 in colonic biopsies of PD patients. Background: Neuroinflammation is emerging as a key factor involved in the pathophysiology…
  • 2024 International Congress

    Investigation of the Beta Oscillations of Local Field Potential in the Subthalamic Nucleus of the Parkinsonian Minipig Model

    HC. Lin, YH. Wu, FY. Liu, MD. Ker (Hsinchu, Taiwan)

    Objective: To investigate the features of beta oscillations of the subthalamic nucleus (STN) in the Parkinsonian minipig model. Background: Deep brain stimulation (DBS) is an…
  • 2024 International Congress

    Harnessing chaperone-mediated autophagy through viral-based LAMP2A overexpression in non-human primates as a Treatment of Parkinson’s Disease

    ML. Arotcarena, M. Fouka, E. Gialinaki, L. Stefanis, E. Bezard, M. Xilouri, B. Dehay (BORDEAUX, France)

    Objective: This project aimed to investigate whether the CMA lysosomal pathway induction may benefit the highest-order mammalian synucleinopathy model, the non-human primate, by targeting CMA’s…
  • 2024 International Congress

    Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

    SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)

    Objective: To investigate differences in clinical subtypes, biomarkers, and course of progression in Parkinson’s disease (PD) between the two biological sexes. Background: PD is a…
  • « Previous Page
  • 1
  • …
  • 262
  • 263
  • 264
  • 265
  • 266
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley